Evidence map›Paper›PMID 30185554›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Structure of the membrane proximal external region of HIV-1 envelope glycoprotein.

Qingshan Fu, Md Munan Shaik, Yongfei Cai, Fadi Ghantous, Alessandro Piai, Hanqin Peng, Sophia Rits-Volloch, Zhijun Liu, Stephen C Harrison, Michael S Seaman and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Conformational Variability of HIV-1 Env Trimer and Viral Vulnerability.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Qingshan FuDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Md Munan ShaikDivision of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Yongfei CaiDivision of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Fadi GhantousCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215.
Alessandro PiaiDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0002-5264-1980
Hanqin PengDivision of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Sophia Rits-VollochDivision of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Zhijun LiuState Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Science Research Center, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, 201203 Shanghai, China.
Stephen C HarrisonDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; harrison@crystal.harvard.edu bchen@crystal.harvard.edu james_chou@hms.harvard.edu.
Michael S SeamanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215.
Bing ChenDivision of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115; harrison@crystal.harvard.edu bchen@crystal.harvard.edu james_chou@hms.harvard.edu.
James J ChouDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; harrison@crystal.harvard.edu bchen@crystal.harvard.edu james_chou@hms.harvard.edu.
Boston Children's Hospital · USHarvard University · USBeth Israel Deaconess Medical Center · USChinese Academy of Sciences · CN

Funding

Virus biology scientific research support componentUM1AI100645 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F. · 2012 to 2018
$204.7M
OverallP41EB002026 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GRIFFIN, ROBERT GUY · 2003 to 2018
$17.9M
Structure-function studies of the membrane-interacting domains of HIV-1 Env spikeR01AI127193 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI CHEN, BING, HARRISON, STEPHEN COPLAN · 2016 to 2025
$8.4M
Crystallographic studies of intact and fully glycosylated HIV-1 gp120R01AI106488 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI CHEN, BING · 2013 to 2017
$2.2M
Novel therapeutics targeting the membrane proximal external region of HIV-1 EnvR56AI129721 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI CHEN, BING · 2017 to 2017
$674k
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI106488NIAID NIH HHS R01 AI127193NIAID NIH HHS R56 AI129721NIAID NIH HHS UM1 AI100645NIBIB NIH HHS P41 EB002026
6 · The paper itself

Abstract

The membrane-proximal external region (MPER) of the HIV-1 envelope glycoprotein (Env) bears epitopes of broadly neutralizing antibodies (bnAbs) from infected individuals; it is thus a potential vaccine target. We report an NMR structure of the MPER and its adjacent transmembrane domain in bicelles that mimic a lipid-bilayer membrane. The MPER lies largely outside the lipid bilayer. It folds into a threefold cluster, stabilized mainly by conserved hydrophobic residues and potentially by interaction with phospholipid headgroups. Antigenic analysis and comparison with published images from electron cryotomography of HIV-1 Env on the virion surface suggest that the structure may represent a prefusion conformation of the MPER, distinct from the fusion-intermediate state targeted by several well-studied bnAbs. Very slow bnAb binding indicates that infrequent fluctuations of the MPER structure give these antibodies occasional access to alternative conformations of MPER epitopes. Mutations in the MPER not only impede membrane fusion but also influence presentation of bnAb epitopes in other regions. These results suggest strategies for developing MPER-based vaccine candidates.

Indexed as

env Gene Products, Human Immunodeficiency VirusHIV-1HIV AntigensImmunoglobulin Fab FragmentsLipid BilayersMagnetic Resonance SpectroscopyMembrane FusionProtein DomainsVirionenv Gene Products, Human Immunodeficiency VirusHIV AntigensImmunoglobulin Fab FragmentsLipid BilayersHIV-1 Envmembrane proximal regionNMR structuretransmembrane region

Identifiers

PMID30185554
PMCPMC6156635
OpenAlexW2890453231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.